← Back to headlines
Eli Lilly Expands Pipeline with Positive Trial Data and New Licensing Deal
Eli Lilly (LLY) has announced the expansion of its pharmaceutical pipeline, driven by positive trial data and a new licensing agreement.
23 Feb, 19:51 — 23 Feb, 19:51
Sources
Showing 1 of 1 sources
Related Stories
Study Suggests Syphilis-Like Disease Spread in Ancient Vietnam, Challenging Columbus Theory
just now
Padel for Parkinson’s Cycling Event Held at University of Ghana for Awareness
16m ago
Understanding and Managing Postpartum Sweating
27m ago
Protecting Dogs from Viper Bites as Warmer Weather Arrives
40m ago